ArticleCancer management and research2020

Nimotuzumab Combined with Induction Chemotherapy and Concurrent Chemoradiotherapy in Unresectable Locally Advanced Hypopharyngeal Carcinoma: A Single Institution Experience in China.

Xin Tian et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.